Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jun;17(6):322.
doi: 10.1038/s41569-020-0385-9.

Rivaroxaban reduces ischaemic events in patients with PAD

Affiliations
Comment

Rivaroxaban reduces ischaemic events in patients with PAD

Karina Huynh. Nat Rev Cardiol. 2020 Jun.
No abstract available

PubMed Disclaimer

Comment on

  • Vascular toxic effects of cancer therapies.
    Herrmann J. Herrmann J. Nat Rev Cardiol. 2020 Aug;17(8):503-522. doi: 10.1038/s41569-020-0347-2. Epub 2020 Mar 26. Nat Rev Cardiol. 2020. PMID: 32218531 Free PMC article. Review.
  • Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
    Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.

References

Original article
    1. Bonaca, M. P. et al. Rivaroxaban in peripheral artery disease after revascularization. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2000052 (2020) - DOI - PubMed

LinkOut - more resources